Informação sobre produto
Nome:
AKTI-1/2
Sinónimos:
- [u'1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one', u'1,3-dihydro-PIQPBO', u'Akt inhibitor VIII', u'Akt inhibitor VIII', u'612847-09-3', u'Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2', u'1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one', u'1,3-Dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]-4-piperidinyl]-2H-benzimidazol-2-one', u'1-(1-(4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl)-piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', u'InSolution™ Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2', u'1-(1-((4-(7-Phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)phenyl)methyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', u'1-{1-[(4-{6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl}phenyl)methyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one', u'Akt-I-1/2', u'isozyme-selective, Akti-1/2', u'AKTinhibitorVIII', u'imidazoquinoxaline 16h', u'MLS003509084', u'MLS006010829', u'CHEMBL258844', u'GTPL5921', u'SCHEMBL1078972', u'BDBM15169', u'C34H29N7O', u'CHEBI:91346', u'CTK8F0264', u'KS-00001CRD', u'DTXSID50436572', u'EX-A672', u'cid_10196499', u'HMS3229A11', u'HMS3265G03', u'HMS3265G04', u'HMS3265H03', u'HMS3265H04', u'BCP13210', u'ZINC4846183', u'MFCD09026909', u's7776', u'AKOS016008792', u'AKOS027470284', u'ACN-052935', u'CCG-206733', u'NCGC00165727-01', u'NCGC00165727-02', u'HY-10355', u'SMR002157258', u'SMR004701756', u'RT-011226', u'FT-0661446', u'X2144', u'VU0450226-1', u'W-5386', u'1,3-Dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]guinoxalin-7-yl)phenyl]methyl]4-piperidinyl]-2H-benzimidazol-2-one', u'1,3-Dihydro-1-[1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenylmethyl]-4-piperidinyl]-2H-benzimidazol-2-one', u'1-(1-(4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', u'1-(1-(phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', u'1-{1-[(4-{7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl}phenyl)methyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one', u'1-{1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one', u'3-[1-[[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one', u'3-[1-[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)benzyl]-4-piperidyl]-1H-benzimidazol-2-one', u'IQO', u'imidazoquinoxaline', u'1,3-dihydro-PIQPBO', u'D05APZ', u'CS-0001', u'CID10196499', u'CID 10196499', u'A3149', u'A3153', u'A6730', u'A11286', u'C532657', u'1-(1-(4-(7-Phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', u'1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one']
- 1-{1-[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
- 2H-benzimidazol-2-one, 1,3-dihydro-1-[1-[[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]-4-piperidinyl]-
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Indagoo
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
551.6404
Fórmula:
C34H29N7O
Pureza:
97%
Cor/forma:
Solid
InChI:
InChI=1S/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25,38H,14-17,20H2,(H,39,42)
Chave InChI:
IWCQHVUQEFDRIW-UHFFFAOYSA-N
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
